19 January 2023 - The UK has a “voluntary scheme for branded medicines, pricing, and access” or VPAS, which sets a limit on annual spending on single source prescription drugs by the NHS. 

Companies who participate in the VPAS must refund any excess sales revenue over this limit.

Read Forbes article